# Accelerated PrEP Access for Black MSM and TW

> **NCT04329442** · NA · WITHDRAWN · sponsor: **University of Chicago**

## Conditions studied

- HIV/AIDS

## Interventions

- **DRUG:** Emtricitabine / Tenofovir Disoproxil Oral Tablet

## Key facts

- **NCT ID:** NCT04329442
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-04-01
- **Primary completion:** 2021-07-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** COVID-19 caused substantial barriers to recruitment.
- **Last updated:** 2022-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04329442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04329442, "Accelerated PrEP Access for Black MSM and TW". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04329442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*